A pilot study of immune checkpoint inhibition (tremelimumab and/or MEDI4736) in combination with radiation therapy in patients with unresectable pancreatic cancer.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Austin G. Duffy, Oxana V. Makarova-Rusher, Drew Pratt, David E Kleiner, Christine Alewine, Suzanne Fioravanti, Melissa Walker, Stephanie Carey, William Douglas Figg, Seth M. Steinberg, Victoria Anderson, Elliot Levy, Venkatesh Krishnasamy, Bradford J. Wood, Jennifer Jones, Deborah E. Citrin, Tim F. Greten
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2591204696